To homepage

Best Hormone Therapy Doctors Abroad

Content meets the Bookimed Editorial Policy and is medically reviewed by

Yesim Yildirim

Yesim Yildirim

  • 4.6 Excellent • 544 reviews
  • 22 years of experience
  • accreditations:
  • Turkey, Istanbul, Anadolu Medical Center
  • Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 publications in medical oncology.

    • Member of European Society of Medical Oncology (ESMO)
    • Expert in breast, gastrointestinal, and lung cancers
    • Professor at Halic University, Istanbul
    • Completed advanced training in Melanoma and Kidney Cancer Clinic in London
  • Read more
Doctor's visit
Price on request
Info

María Teresa Gómez Sugrañes

  • 4.7 Excellent • 497 reviews
  • 26 years of experience
  • Spain, Barcelona, Centro Médico Teknon
Package price from
$600
Info

Eda Tanrıkulu Şimşek

  • 4.6 Excellent • 544 reviews
  • 21 years of experience
  • Turkey, Istanbul, Anadolu Medical Center
  • Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

    • Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
    • Participated in global training at Oxford University and ESMO in Manchester.
    • Treats gastrointestinal, urological, lung, and breast cancers.
    • Member of the American and European Societies of Medical Oncology.
  • Read more
Doctor's visit
Price on request
Info

Wolfgang Köstler

  • 4.6 Excellent • 175 reviews
  • 22 years of experience
  • Austria, Vienna, Wiener Privatklinik (WPK)
  • Prof. Köstler is a leading expert in personalized cancer medicine, specializing in breast and gynecologic cancers with over two decades of experience.

    • Associate Professor at the Medical University of Vienna
    • Deputy Head of the Clinical Division of Oncology
    • Pioneer in targeted therapies and translational research
    • Senior consultant at Wiener Privatklinik
  • Read more
Doctor's visit
Price on request
Info

Dr. Sezer Saglam

  • 5 Excellent • 58 reviews
  • 29 years of experience
  • accreditations:
  • Turkey, Istanbul, Istanbul Florence Nightingale Hospital
  • Professor of Medical Oncology with 29 years of experience in hormone therapy at Istanbul Florence Nightingale Hospital.

    • Specializes in gastrointestinal oncology since 2005
    • Fellowship-trained at Istanbul University Oncology Institute
    • Member of ESMO, ASCO, and European Neuroendocrine Tumor Society
  • Read more
Doctor's visit
Price on request
Info

Viola Fox

  • 4.7 Excellent • 69 reviews
  • 14 years of experience
  • Germany, Solingen, Medical Center in Solingen
  • Dr. Viola Fox leads the certified cancer center at BKZ Solingen, specializing in advanced hormone therapies for tumor diseases.

    • Over 14 years of experience in hematology and oncology
    • Qualified specialist in genetics with research in molecular biology
    • Member of the American Association for Cancer Research
    • Develops and implements innovative treatments for haemato-oncological diseases
  • Read more
Doctor's visit
Price on request
Info

Irina Stepfansky

  • 4.5 Good • 172 reviews
  • 26 years of experience
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads hormone therapy programs at one of Israel's top hospitals.

    • 26 years specializing in oncology and internal medicine
    • Primary researcher in multiple clinical trials for oncology treatments
    • Trained at Tel Aviv Medical Center's prestigious oncology program
    • Expert in both diagnosis and management of hormonal therapies
  • Read more
Doctor's visit
Price on request
Info

Sonnenblick Amir

  • 4.5 Good • 172 reviews
  • 19 years of experience
  • Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
  • Dr. Amir specializes in hormone therapy for breast cancer at Sourasky Medical Center, with awards from ESMO and ISCORT for his research.

    • Over 30 presentations at national and international scientific meetings
    • ESMO Breast Cancer Translational Research Fellowship at Jules Bordet Institute
    • Member of European Society of Medical Oncology (ESMO)
    • Recipient of multiple awards including ISCORT Best Paper of the Year
  • Read more
Doctor's visit
Price on request
Info

Mustafa Serkan Alemdar

  • 4.4 Good • 8 reviews
  • 20 years of experience
  • Turkey, Antalya, Medical Park Antalya Hospital Complex
  • Dr. Alemdar specializes in hormone therapy with extensive training in medical oncology at Akdeniz University.

    • 20 years of experience in internal medicine and oncology
    • Trained at Akdeniz University, a leading medical institution
    • Works at Medical Park Antalya Hospital Complex
  • Read more
Package price from
$1,100
Info

Cagdas Erdogan

  • 5 Excellent • 1 review
  • 12 years of experience
  • Turkey, Istanbul, İstinye University Liv Hospital Topkapı
  • Specializes in advanced endoscopic procedures with a focus on inflammatory bowel disease (IBD) treatment at İstinye University Liv Hospital Topkapı.

    • Clinical Fellowship in Gastroenterology from Ankara City Hospital
    • Published multiple studies on IBD treatment outcomes
    • Expert in endoscopic mucosal resection (EMR) and submucosal dissection (ESD)
    • Active researcher with articles in peer-reviewed journals
  • Read more
Doctor's visit
Price on request
Info

Li Gui Yuan

  • New
  • 23 years of experience
  • China, Shanghai, Shanghai Tongji Hospital, International Department
  • Li Guiyuan, MD, is Chief Physician in the Department of Medical Oncology at Shanghai Tongji Hospital. He has practiced oncology since 1996 and has more than 20 years of experience. He earned a master’s degree in Oncology from Nanjing University in 2003. He has worked in the hospital’s Oncology Department since then.

    His clinical work includes chemotherapy for lung, breast, ovarian, and gastrointestinal cancers. He also provides targeted and anti‑angiogenic therapies for malignant tumours. He manages malignant pleural and peritoneal effusions and bone metastases with multimodal care, including immunotherapy.

    He has authored more than 10 basic and clinical papers, including “Tumour Hypoxia and Its Therapeutic Strategies” and “Establishment of Tumour Model with B16 Melanoma Cell Line of C57BL/6 Mice in ICR Mice.” He received the Medical Achievement Award from the General Logistics Department of the PLA for “Research and Application of Early‑diagnosis and Prediction Model for Metastasis of Non‑small‑cell Lung Cancer.” He co‑authored “Evidence‑based Oncology Treatment” and “Handbook of Modern Evidence‑based Diagnosis and Treatment of Cancer.” He has also taken part in key projects of the National Natural Science Foundation of China.

  • Read more
Doctor's visit
Price on request
Info

Irfan Cicin

  • 5 Excellent • 1 review
  • 29 years of experience
  • Turkey, Istanbul, İstinye University Liv Hospital Topkapı
  • Professor Cicin specializes in hormone therapy with over 29 years of experience in medical oncology at Trakya University.

    • Completed fellowship in Medical Oncology at Trakya University
    • Associate Professor and later Professor at Trakya University Faculty of Medicine
    • Member of the Turkish Medical Oncology Association
  • Read more
Doctor's visit
Price on request
Info

Shute Ailia Dae

  • 5 Excellent • 1 review
  • 13 years of experience
  • Turkey, Tekirdag, Optimed International Hospital
  • Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

    From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

    Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

  • Read more
Doctor's visit
Price on request
Info

Alexander Hauswirth

  • 27 years of experience
  • Austria, Vienna, JUVENIS
  • Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

    He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

    Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

  • Read more
Doctor's visit
Price on request
Info

Wlodzimierz Zych

  • 39 years of experience
  • Poland, Warsaw, LUX MED Szpital św. Elżbiety
  • Dr. Wlodzimierz Zych is a gastroenterologist and hepatologist. He treats liver and digestive diseases. His work includes cholestatic, autoimmune, and metabolic liver disorders. He also manages hemochromatosis, celiac disease, and inflammatory bowel disease.

    Education and accreditation: MD, 1987, First Faculty of Medicine, Medical Academy in Warsaw. PhD, 1994, CMKP. Specialist in internal medicine, 1996. Specialist in gastroenterology, 2004.

    Experience: Started in 1988 as a Junior Assistant at the Dept. of Gastroenterology and Hepatology, CMKP. Served as Assistant Professor and Head of the Hepatology Subunit until 2013. From 1994 to 2015, affiliated with the Dept. of Oncological Gastroenterology, Oncology Centre in Warsaw.

    Academic achievements: Lecturer and academic teacher. Author and co-author of many scientific papers and textbook chapters. Long-term participant in the Screening Program for Early Detection of Colorectal Cancer.

  • Read more
Doctor's visit
Price on request
Info

Lars Bönicke

  • 15 years of experience
  • Germany, Wuppertal, Helios Gesundheit
Doctor's visit
Price on request
Info

Zhang Jinshan

  • 41 years of experience
  • 50000+ treatments performed
  • China, Chengdu, Uni-asia Cancer hospital
  • Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

    1980–1985: Completed doctoral studies at Nagasaki University, Japan

    1968–present: Department of Radiology, Chinese PLA General Hospital

    1988: Third Prize of the Military Science and Technology Progress Award

    1989–present: Member of Radiological Society of North America(RSNA)

    1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

    1991: Second Prize of the Military Science and Technology Progress Award

    1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

    1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

    1993: Granted the Lifetime Special Government Allowance of the State Council

    1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

    1994: Third Prize of the Military Science and Technology Progress Award

    1997: Second Prize of the Military Science and Technology Progress Award

    1997–2009: Standing Member of Chinese Society of Radiology

    1999: Third Prize of the Military Science and Technology Progress Award

    1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

    2002: Second Prize of the Military Science and Technology Progress Award

    2005: Third Prize of the Military Science and Technology Progress Award

    Member of Radiological Society of North America(RSNA)

    Standing Member of Chinese Society of Radiology

    Group Leader of the Group of Intervention of Chinese Journal of Radiology

    Deputy Director Member of Chinese Society of Interventional Oncology

    Director Member of Beijing Medical Association Society of Interventional Radiology

    Deputy Chief Editor of Chinese Journal of Medical Image Technology

    Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

    Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

    Awarded the Special Government Allowance of the State Council

    Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

    Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

    Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

    In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

    zhang-jin-shan

    Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

    zhang-jin-shan

    In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

    zhang-jin-shan

    Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

    zhang-jin-shan

    From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

    Professor Zhang Jinshan’s Academic Achievements

    Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

    Selected Publications by Professor Zhang Jinshan

    1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993,27(6):361-365.

    Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

    2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996,30(8):521-524.

    Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

    3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998,14(3):189-191.

    Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

    4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000,34(5):335-337.

    Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

    5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002,36(7):612-614.

    Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

    6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004,20(9):1395-1397.

    Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

    7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006,40(8):876-878.

    Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

    8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008,28(10):856-858.

    Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

    Professor Zhang Jinshan co-authored monographs

    1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

    2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

    3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

    Professor Zhang Jinshan’s Research project

    1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

    2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

    3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

    4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

  • Read more
Doctor's visit
Price on request
Info

Raanan Berger

  • 5 Excellent • 2 reviews
  • 27 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

    • Heads the clinical research unit focusing on molecular oncology.
    • Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
    • Member of the American Society of Clinical Oncology (ASCO).
    • Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.
  • Read more
Doctor's visit
Price on request
Info

Jair Bar

  • 5 Excellent • 2 reviews
  • 35 years of experience
  • Israel, Ramat Gan, Sheba Medical Center
  • Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

    • Chair of the Israel Lung Cancer Group.
    • Board-certified in both Medical Oncology and Radiotherapy Oncology.
    • Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
    • Uses molecular and genetic profiling to create precise cancer treatment plans.
  • Read more
Doctor's visit
Price on request
Info

Wolfgang Schröder

  • 25 years of experience
  • Germany, Wuppertal, Helios Gesundheit
Doctor's visit
Price on request
Info